Biocompatible poly-β-1→4-N-acetylglucosamine
AssigneeMarine Polymer Technologies, Inc.
InventorsJohn N. Vournakis, Sergio Finkielsztein, Ernest R. Pariser, Mike Helton
Life of this patent
Estimating the term…
Loading patent…
AssigneeMarine Polymer Technologies, Inc.
InventorsJohn N. Vournakis, Sergio Finkielsztein, Ernest R. Pariser, Mike Helton
Estimating the term…
The present invention relates to a purified, easily produced poly-β-1→4-N-acetylglucosamine (p-GlcNAc) polysaccharide species. The p-GlcNAc of the invention is a polymer of high molecular weight whose constituent monosaccharide sugars are attached in β-1→4 conformation, and which is free of proteins, and substantially free of single amino acids, and other organic and inorganic contaminants. In addition, derivatives and reformulations of p-GlcNAc are described. The present invention further relates to methods for the purification of the p-GlcNAc of the invention from microalgae, preferably diatom, starting sources. Still further, the invention relates to methods for the derivatization and reformulation of the p-GlcNAc. Additionally, the present invention relates to the uses of pure p-GlcNAc, its derivatives, and/or its reformulations.
A biocompatible poly-β-1→4-N-acetylglucosamine comprising up to about 150,000 N-acetylglucosamine monosaccharides covalently attached in a conformation and having a molecular weight of up to about 30 million daltons.
A biocompatible poly-β-1→4-N-acetylglucosamine comprising up to about 150,000 N-acetylglucosamine monosaccharides covalently attached in a β-1→4 conformation and having a molecular weight of up to about 30 million daltons in which at least one N-acetylglucosamine monosaccharide has been deacetylated.
The biocompatible poly-β-1→4-N-acetylglucosamine of 7 claim wherein at least about 25% to about 75% of the N-acetylglucosamine monosaccharides have been deacetylazed.
A biocompatible poly-β-1→1-glucosamine comprising up to about 150,000 glucosamine monosaccharides covalently attached in a β-1→4 conformation, and having a molecular weight of up to about 24 million daltons.
A biocompatible poly-β-1→4-glucosamine comprising up to about 150,000 glucosamine monosaccharides covalently attached in a β-1→4 conformation, wherein at least one glucosamine monosaccharide has been acetylated.
Dependencies are inferred from the claim text.